UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight

Advances in experimental medicine and biology, 2008, Vol.624, p.89

2008

Volltextzugriff (PDF)

Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036

European journal of cancer (1990), 2021-07, Vol.152, p.18-25

2021

Volltextzugriff (PDF)

Melanoma epidemiology and trends

Clinics in dermatology, 2009, Vol.27 (1), p.3-9

2009

Volltextzugriff (PDF)

BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanoma

Journal of the European Academy of Dermatology and Venereology, 2024-09, Vol.38 (9), p.e779

2024

Volltextzugriff (PDF)

Update – Systemtherapie beim Basalzellkarzinom

Journal der Deutschen Dermatologischen Gesellschaft, 2021-09, Vol.19 (9), p.1399-1400

2021

Volltextzugriff (PDF)

Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?

International journal of molecular sciences, 2020-12, Vol.21 (23), p.9300

2020

Volltextzugriff (PDF)

Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients

Journal of the European Academy of Dermatology and Venereology, 2024-04, Vol.38 (4), p.741-751

2024

Volltextzugriff (PDF)

Neue Leitlinien zu seltenen Hauttumorentitäten

Journal der Deutschen Dermatologischen Gesellschaft, 2023-02, Vol.21 (2), p.221-222

2023

Volltextzugriff (PDF)

Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany

Acta dermato-venereologica, 2022-01, Vol.102, p.adv00637-adv00637

2022

Volltextzugriff (PDF)

Komitee „kutane Sarkome und seltene Tumorentitäten

Journal der Deutschen Dermatologischen Gesellschaft, 2022-05, Vol.20 (5), p.743-743

2022

Volltextzugriff (PDF)

Outcome and treatment-related adverse events of combined immune checkpoint inhibition with flipped dosing in a real-world cohort of 79 patients with metastasized melanoma

Frontiers in oncology, 2023-11, Vol.13, p.1256800-1256800

2023

Volltextzugriff (PDF)

Clinical determinants of long-term survival in metastatic uveal melanoma

Cancer Immunology, Immunotherapy, 2022-06, Vol.71 (6), p.1467-1477

2022

Volltextzugriff (PDF)

Epidemiology of Skin Cancer: Update 2019

Sunlight, Vitamin D and Skin Cancer, p.123-139

Volltextzugriff (PDF)

Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors

Targeted oncology, 2021-03, Vol.16 (2), p.197-205

2021

Volltextzugriff (PDF)

Melanoma-specific survival of patients with uveal melanoma and liver metastases diagnosed between 2005 and 2021

Therapeutic advances in medical oncology, 2024-01, Vol.16, p.17588359241273020

2024

Volltextzugriff (PDF)

Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy

PloS one, 2013-11, Vol.8 (11), p.e81624-e81624

2013

Volltextzugriff (PDF)

Current diagnosis and treatment of basal cell carcinoma

Journal der Deutschen Dermatologischen Gesellschaft, 2015-09, Vol.13 (9), p.863-875

2015

Volltextzugriff (PDF)

Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions: Non-interventional Cohort Study JONAS

Acta dermato-venereologica, 2022-04, Vol.102, p.adv00695-adv00695

2022

Volltextzugriff (PDF)

Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors

Cancer Immunology, Immunotherapy, 2021-04, Vol.70 (4), p.1089-1099

2021

Volltextzugriff (PDF)

Micrographic Surgery Allows Fascia Preservation in Dermatofibrosarcoma Protuberans

Acta dermato-venereologica, 2021-09, Vol.101 (9), p.adv00561-adv00561

2021

Volltextzugriff (PDF)

Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003198

2022

Volltextzugriff (PDF)

The natural course of cutaneous melanoma

Journal of surgical oncology, 2004-07, Vol.86 (4), p.172-178

2004

Volltextzugriff (PDF)

Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG

Journal for immunotherapy of cancer, 2022-11, Vol.10 (11), p.e005930

2022

Volltextzugriff (PDF)

1 – 25 von 286

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(242)
Mit Volltextzugriff
(254)

Publikationsform

Artikel
(260)
Buchkapitel
(20)
Bücher
(4)
Berichte
(2)

Sprache

Englisch
(229)
Deutsch
(66)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight

Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036

Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

Melanoma epidemiology and trends

BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanoma

Update – Systemtherapie beim Basalzellkarzinom

Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?

Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients

Neue Leitlinien zu seltenen Hauttumorentitäten

Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany

Komitee „kutane Sarkome und seltene Tumorentitäten

Outcome and treatment-related adverse events of combined immune checkpoint inhibition with flipped dosing in a real-world cohort of 79 patients with metastasized melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

Epidemiology of Skin Cancer: Update 2019

Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors

Melanoma-specific survival of patients with uveal melanoma and liver metastases diagnosed between 2005 and 2021

Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy

Current diagnosis and treatment of basal cell carcinoma

Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions: Non-interventional Cohort Study JONAS

Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors

Micrographic Surgery Allows Fascia Preservation in Dermatofibrosarcoma Protuberans

Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma

The natural course of cutaneous melanoma

Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events

Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG

Suchergebnisse filtern